EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The award recognizes and supports promising female scientists working in mass spectrometry
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
India has a pivotal role in eliminating TB
Subscribe To Our Newsletter & Stay Updated
